drugset / Trial / NCT06679998
A Phase I Clinical Trial Evaluating the Safety, Tolerability and Pharmacokinetics of AAPB for Injection
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This is a Phase I clinical to evaluate the safety and tolerability of single and multiple intravenous infusions of AAPB at different doses over 7 consecutive days.
Timeline
- Start
- 2024-11-14
- Primary completion
- 2026-01-12
- Completion
- 2026-03-26
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AAPB | Unknown | 10 mg | Intravenous |
| Subject | AAPB | Unknown | 25 mg | Intravenous |
| Subject | AAPB | Unknown | 50 mg | Intravenous |
| Subject | AAPB | Unknown | 75 mg | Intravenous |
| Subject | AAPB | Unknown | 100 mg | Intravenous |